Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A complete regulatory guide to lisinopril's FDA approval history, compounding legal status, labeling requirements, and post-market safety data, with primary-source citations throughout.
Read clinical reviewA detailed review of lisinopril safety signals in the FDA Adverse Event Reporting System (FAERS), covering angioedema, cough, hyperkalemia, renal events, and how post-market data has shaped prescribing guidance.
Read clinical reviewA comprehensive review of lisinopril's regulatory history across the FDA, EMA, and global agencies, including approval timelines, label updates, post-market surveillance, and current prescribing status.
Read clinical reviewA comprehensive review of lisinopril FDA label updates from 2020 through 2026, covering new safety warnings, post-market surveillance findings, and prescribing changes for this widely used ACE inhibitor.
Read clinical reviewA clinician-reviewed guide to lisinopril's regulatory history, patent timeline, generic entry, FDA label changes, and post-market safety surveillance, with primary-source citations throughout.
Read clinical reviewA detailed comparison of how the European Medicines Agency and the U.S. FDA regulate lisinopril, covering approval history, labeling differences, post-market surveillance, and safety signals.
Read clinical review